Emgality is an injection with galcanezumab in its composition, which has already been approved in the United States of America, for the preventive treatment of migraine in adults.
This medication, produced by Lilly laboratories, must be administered once a month, and the administration can be performed at home, by the person himself.
How to use
Emgality is an injection that must be administered subcutaneously, in the abdomen, thigh, back of the arm or buttocks. This injection can be administered at home, by the person himself, who must be properly trained to do it, by a health professional.
The recommended dose is 240 mg, administered in two consecutive doses of 120 mg, followed by monthly doses of 120 mg.
Who should not use
This remedy is contraindicated for people who are hypersensitive to any of the components of the formula.
In addition, it should also not be administered to pregnant women, women who are breastfeeding and children, as there are no studies that prove the safety of the drug in these cases.
The doctor must also be informed about any medication that the person is taking, in order to prevent drug interactions from occurring.
See other remedies that are used to treat migraine.
Possible side effects
The most common side effects that can occur with the use of this medication are reaction at the injection site.
In addition, although it is rare, an allergic reaction can occur with symptoms such as swelling of the face, mouth, tongue and throat and difficulty breathing.
